Placebo response in migraine
نویسندگان
چکیده
منابع مشابه
Placebo response in clinical randomized trials of analgesics in migraine.
The objective was to assess the placebo response in randomized clinical trials of analgesics in the treatment of migraine attacks. We included placebo-controlled studies that used the criteria of the International Headache Society for the diagnosis of migraine and headache response as the primary efficacy parameter. In the 11 studies that qualified for inclusion, headache response occurred afte...
متن کاملPlacebo response in the prophylaxis of migraine: a meta-analysis.
BACKGROUND Migraine constitutes a good model for the study of placebo response. It is a well-defined disease, affects a large population and a great number of clinical trials have been performed, which have given homogeneous outcomes. AIM The aim of this meta-analysis is to evaluate the placebo response rate in migraine prophylaxis in all published clinical trials since 1988 and to estimate t...
متن کاملIntranasal sumatriptan study with high placebo response in Taiwanese patients with migraine.
BACKGROUND Triptan's efficacy in the treatment of migraine has never been reported in Taiwanese. A high placebo effect was reported in Japanese. The objective of this study was to evaluate the efficacy of intranasal sumatriptan in the acute treatment of migraine in Taiwanese patients. METHODS Fifty-eight patients who had experienced migraine for at least 1 year were randomly assigned to 2 gro...
متن کاملMigraine Trigger Site Surgery is All Placebo.
BACKGROUND Over the last decade surgical treatments for migraine involving proposed trigger sites have been described and popularized by plastic surgeons in particular. Various related techniques aim to free up "trigger sites" by removal of small facial muscles or "decompressing" small facial nerves. DISCUSSION The basis for migraine trigger site surgery is without merit. There is one positiv...
متن کاملPlacebo response in trichotillomania
Trichotillomania is a functionally impairing, often overlooked disorder with no Food and Drug Administration-approved medications indicated for its treatment. The ability of clinical trials to detect the beneficial effects of pharmacologic treatment in trichotillomania has been hampered by the high placebo response rate. Very little is known about baseline demographic and clinical characteristi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Clinical Pharmacology
سال: 2010
ISSN: 0031-6970,1432-1041
DOI: 10.1007/s00228-010-0953-8